Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Price weighting determines index movements by share price rather than market value, impacting index behavior. This intro explains how to identify price weighted indices and what it means for investors.
25,517 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Analysts released a fresh batch of top calls on Thursday, reshaping sentiment across industrials and tech as earnings...
In May 2026, two fresh tech IPOS are catching the eye of diligent investors. This guide breaks down why they stand ou...
Iran's Kharg Island oil terminal has halted loading for multiple days as President Trump arrives in Beijing. The disr...
This article outlines why rental properties can redefine how the average American builds wealth. It offers actionable...
A new AI platform launch aims to empower independent brokerages to stay independent, compete scale, and win at scale ...
A spotlight on KNG shows it earns an 8.6% yield by selling covered calls on Dividend Aristocrats, but eight-year retu...
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
A big multi-system order helped Camtek push its stock higher as investors weighed the implications for backlog, margi...
As bond markets flash warnings and oil risk climbs from Gulf tensions, a leading wall street strategist warns that th...
When a top executive sells a chunk of stock, it draws attention. This guide examines brian chesky just sold, what ins...
Oil prices slipped Friday as investors weighed the possibility of a U.S.-Iran peace deal that could reopen the Strait...